Verseon (LSE:VERS) Total Equity : £18.92 Mil (As of Jun. 2019)

View and export this data going back to 2015. Start your Free Trial

What is Verseon Total Equity?

Verseon's total equity for the quarter that ended in Jun. 2019 was £18.92 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Verseon Total Equity Historical Data

The historical data trend for Verseon's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verseon Total Equity Chart

Verseon Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Total Equity

Get a 7-Day Free Trial

-2.77

56.01

52.02

33.73

19.91

Verseon Semi-Annual Data
	Dec11	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19
Total Equity	Get a 7-Day Free Trial									43.83	33.73	26.74	19.91	18.92

Verseon Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Verseon's Total Equity for the fiscal year that ended in Dec. 2018 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2018 )	-	Total Liabilities(Q: Dec. 2018 )
	=	44.524	-	24.619
	=	19.91

Verseon's Total Equity for the quarter that ended in Jun. 2019 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2019 )	-	Total Liabilities(Q: Jun. 2019 )
	=	45.459	-	26.542
	=	18.92

Verseon Total Equity Related Terms

Thank you for viewing the detailed overview of Verseon's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Verseon (LSE:VERS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verseon Corp (LSE:VERS) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

47071 Bayside Parkway, Fremont, CA, USA, 94538

Website

http://www.verseon.com

Verseon Corp is a part of the healthcare sector in the United States. It is a technology-based pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates that are unlikely to be found using conventional methods. It is also engaged in drug discovery programs such as the diabetic macular edema product candidates, which treat the diseases by controlled disruption of the kallikrein kinin cascade.